This Viewpoint discusses factors that play a role in the low rate of lipid screening in children, including a lack of compelling evidence, disagreement with recommendations, and concerns for overdiagnosis and overtreatment. Share: Previous Post Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines Low-Intensity Social Care and Child Acute Health Care Utilization Clinical Practice Guidelines Testing Bidirectional Associations Between Maternal and Child Depression During Emerging Adolescence Clinical Practice Guidelines Clarifying Associations of Individual Factors With Medical School Attrition—Reply Clinical Practice Guidelines Medicaid Accountable Care Organizations and Disparities in Pediatric Asthma Care Clinical Practice Guidelines Physical Activity in Children Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.